People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

A pill from Eli Lilly helped patients improve their blood sugar and shed weight, results that could propel the ...

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

Dr. Bernstein's Diabetes Diet is a very low-carbohydrate diet designed to help people with diabetes achieve and maintain normal blood sugar levels and reverse and/or lower the risk of complications.

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP-1 agonists are used for weight loss in people ...

The “Misery” star went on a weight-loss journey several years ago after being diagnosed with Type 2 diabetes. The Oscar winner admitted to the magazine that she “used to eat terribly ...